Seaport, Hemab price IPOs, while Avalyn soars in Nasdaq debut

May 1, 2026 07:34 AM EDT IPOs Sea­port, Hemab price IPOs, while Ava­lyn soars in Nas­daq de­but Max Gelman Senior Editor A trio of biotechs priced their IPOs on Thurs­day in­to Fri­day morn­ing, set­ting the stage for their pub­lic trad­ing de­buts with more than $850 mil­lion … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER